glycyrrhizic acid has been researched along with Hepatitis C in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goda, Y; Hakamatsuka, T; Hosoe, J; Kamakura, H; Maruyama, T; Masada, S; Tokumoto, H; Tsujimoto, T; Uchiyama, N | 1 |
| Furutani, T; Gondo, T; Hidaka, I; Hino, K; Kawano, H; Korenaga, M; Nishina, S; Sakai, A; Sakaida, I; Shinozaki, A | 1 |
| Fujiyama, S; Hirokawa, S; Masaki, T; Miyakawa, K; Ohkawa, S; Tamai, S; Tanaka, K; Tarao, K | 1 |
| Abe, Y; Kato, T; Kohli, Y; Ueda, T | 1 |
| Arai, K; Okuno, T; Shindo, M | 2 |
| Kameyama, T; Nagao, Y; Sata, M; Tanikawa, K | 1 |
| Kiriyama, S; Kumada, T; Nakano, S; Osada, T; Samori, T; Shimada, S; Sugiyama, K; Takahashi, M; Takeda, I; Toyoda, H | 1 |
| Da Nagao, Y; Itoh, K; Kameyama, T; Sata, M; Suzuki, H; Tanikawa, K | 1 |
| Arase, Y; Chayama, K; Ikeda, K; Kobayashi, M; Koida, I; Kumada, H; Murashima, N; Saitoh, S; Suzuki, Y; Tsubota, A | 1 |
| Patrick, L | 1 |
| Harada, H; Kamitsukasa, H; Kojima, H; Murai, S; Tokita, H; Yagura, M | 1 |
| Ishikawa, H; Kakisaka, Y; Kashima, K; Mitsuyoshi, H; Nakajima, Y; Nakamura, H; Nakashima, T; Sumida, Y; Yodoi, J; Yoh, T | 1 |
| Kumada, H | 1 |
| Iwamura, K; Ohta, W | 1 |
2 review(s) available for glycyrrhizic acid and Hepatitis C
| Article | Year |
|---|---|
[Efficacy of interferon combined glycyrrhizin therapy in patients with chronic hepatitis C resistant to interferon therapy].
Topics: Adult; Aged; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Hepatitis, Chronic; Humans; Interferon-alpha; Male; Middle Aged | 1994 |
Hepatitis C: epidemiology and review of complementary/alternative medicine treatments.
Topics: Antioxidants; Antiviral Agents; Catechin; Complementary Therapies; Disease Progression; Glycyrrhizic Acid; Hepacivirus; Hepatitis C; Humans; Phytosterols; Plant Extracts; Ribavirin; Silymarin | 1999 |
2 trial(s) available for glycyrrhizic acid and Hepatitis C
| Article | Year |
|---|---|
[Efficacy of interferon combined glycyrrhizin therapy in patients with interferon-resistant chronic hepatitis C].
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Chronic Disease; Drug Resistance; Drug Therapy, Combination; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged | 1995 |
Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection.
Topics: Adult; Aged; Antiviral Agents; Chronic Disease; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Humans; Injections, Intravenous; Lichen Planus, Oral; Male; Middle Aged; Probability; Treatment Outcome | 1996 |
11 other study(ies) available for glycyrrhizic acid and Hepatitis C
| Article | Year |
|---|---|
Chemical Analysis of Counterfeit Hepatitis C Drug Found in Japan.
Topics: Antiviral Agents; Benzimidazoles; Chromatography, Liquid; Counterfeit Drugs; Drugs, Chinese Herbal; Ephedrine; Fluorenes; Gas Chromatography-Mass Spectrometry; Glycyrrhizic Acid; Hepatitis C; Japan; Magnetic Resonance Spectroscopy; Mass Spectrometry; Sofosbuvir; Tablets; Uridine Monophosphate; Vitamins | 2017 |
A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice.
Topics: Animals; Cysteine; DNA Primers; Dose-Response Relationship, Drug; Drug Combinations; Fatty Liver; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Immunoblotting; Iron; Iron, Dietary; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron, Transmission; Mitochondria; Oxidative Stress; Reactive Oxygen Species; Statistics, Nonparametric; Sterol Regulatory Element Binding Protein 1 | 2011 |
Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Topics: Alanine Transaminase; Analysis of Variance; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Cholagogues and Choleretics; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Glycyrrhizic Acid; Hepacivirus; Hepatitis C; Humans; Incidence; Inflammation; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Male; Middle Aged; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid | 2005 |
[Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C].
Topics: Adult; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Humans; Interferons; Male; Middle Aged | 1994 |
A case of oral lichen planus with chronic hepatitis C successfully treated by glycyrrhizin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Chronic Disease; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Humans; Infusions, Intravenous; Lichen Planus, Oral; Male; Middle Aged | 1995 |
[The pharmacokinetics of the glycyrrhizin and glycyrrhetic acid after intravenous administration of glycyrrhizin for the patients with chronic liver disease caused by type C hepatitis virus].
Topics: Aged; Antiviral Agents; Chronic Disease; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Humans; Infusions, Intravenous; Liver Cirrhosis; Male; Middle Aged | 1995 |
The long term efficacy of glycyrrhizin in chronic hepatitis C patients.
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Cause of Death; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Hepatitis, Chronic; Humans; Japan; Liver Neoplasms; Long-Term Care; Male; Middle Aged; Regression Analysis; Retrospective Studies | 1997 |
Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-alpha therapy: including quantitative assessment by a morphometric method.
Topics: Alanine Transaminase; Antiviral Agents; Biomarkers; Biopsy; Disease Progression; Drugs, Chinese Herbal; Female; Glycyrrhizic Acid; Hepatitis C; Hepatitis C, Chronic; Humans; Injections, Intramuscular; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Peptide Fragments; Procollagen; Retrospective Studies; RNA, Viral; Ursodeoxycholic Acid | 2000 |
Thioredoxin levels in the sera of untreated viral hepatitis patients and those treated with glycyrrhizin or ursodeoxycholic acid.
Topics: Adult; Aged; Case-Control Studies; Female; Glycyrrhizic Acid; Hepatitis B; Hepatitis C; Humans; Indocyanine Green; Lipid Peroxides; Male; Middle Aged; Oxidative Stress; Thioredoxins; Ursodeoxycholic Acid | 2000 |
Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma.
Topics: Alanine Transaminase; Antiviral Agents; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Chronic Disease; Glycyrrhizic Acid; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Survival Analysis | 2002 |
[Treatment of non-A, non-B hepatitis with glycyrrhizin].
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Drug Evaluation; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Liver; Male; Middle Aged | 1988 |